Anika Therapeutics Inc. (ANIK) Given Average Recommendation of "Strong Buy" by Analysts

Anika Therapeutics Inc. (ANIK) Given Average Recommendation of "Strong Buy" by Analysts

Anika Therapeutics Inc. has earned a consensus broker rating score of 1.00 from the one analysts that cover the company, Zacks Investment Research reports. One analyst has rated the stock with a strong buy recommendation.

from Biotech News